| Nov 12 |
3 Stocks Seeing Insider Buys: CNC, PFE, BMY
|
| Nov 12 |
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
|
| Nov 12 |
AbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains
|
| Nov 12 |
Bristol-Myers upgraded at Leerink after AbbVie setback
|
| Nov 12 |
What the NFL Draft Can Teach Investors About Big Pharma
|
| Nov 11 |
Bristol-Myers Squibb Company (BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference (Transcript)
|
| Nov 11 |
AbbVie tumbles on drug test disappointment, Bristol-Myers gains
|
| Nov 11 |
Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?
|
| Nov 11 |
AbbVie Stock Sinks After Schizophrenia Drug Trials Disappoint
|
| Nov 11 |
Bristol Rockets 11% As Investors Question AbbVie's $8.7 Billion 'Mistake'
|
